MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for March 2015


Multiple Sclerosis Partnering 2010-2015
Topics: Multiple Sclerosis (MS), Pharmaceuticals Company Reports
Multiple Sclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
Topics: Multiple Sclerosis (MS), Prescription Drugs
Regions: Global
Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015
Topics: Multiple Sclerosis (MS)
Regions: Global
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015
Topics: Multiple Sclerosis (MS), Drug Discovery
Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Therapeutic Biological Drugs to 2020 Diseases, Devices, Dosing and Forecasts
Topics: Enzymes, Antibody Technologies, Biologics, Hepatitis, Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing, Drug Discovery
Multiple Sclerosis Pipeline Highlights – 2015
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Multiple Sclerosis-API Insights, 2014
Topics: Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
Topics: Multiple Sclerosis (MS), Drug Discovery, Clinical Trial
Regions: Global
Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2014
Topics: Multiple Sclerosis (MS)
Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2014
Topics: Multiple Sclerosis (MS)
Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014
Topics: Multiple Sclerosis (MS)
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Multiple Sclerosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
Topics: Multiple Sclerosis (MS), Drug Discovery, Clinical Trial
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2014
Topics: Multiple Sclerosis (MS)
KOL Insight: Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
Topics: Multiple Sclerosis (MS), Physicians' Offices
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Market Highlights: Italy Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Italy
Update: Multiple Sclerosis Pipeline Highlights – 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Market Highlights: Spain Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Spain
Market Highlights: UK Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: United Kingdom
Multiple Sclerosis - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Global and Chinese Fingolimod Hydrochloride Industry, 2009-2019 Market Research Report
Topics: Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing
Regions: China, Global
Neurotech Industry 2014 Report
Topics: Alzheimer's Disease, Parkinson's Disease, Huntington's, Multiple Sclerosis (MS), Epilepsy, Neurology Devices, Research & Development, CNS/Neurology
Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Pharma-Patient Engagement: insights from patient opinion leaders
Topics: Multiple Sclerosis (MS), Physicians' Offices
Global Multiple Sclerosis Drugs Market : 2014-2018
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Global
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023
Topics: Multiple Sclerosis (MS)
Regions: Global
Physician Views: What drives physician brand loyalty in the ultra-competitive multiple sclerosis market?
Topics: Multiple Sclerosis (MS), Physicians' Offices
Market Highlights: Germany Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Germany
Market Highlights: France Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: France
Market Highlights: Japan Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Japan
Market Highlights: Europe Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Europe
Market Highlights: US Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
Topics: Biologics, Multiple Sclerosis (MS), Biopharmaceuticals
Regions: Global
Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2013
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
Topics: Multiple Sclerosis (MS), Research & Development
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update
Topics: Multiple Sclerosis (MS)
Regions: Global
Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention?
Topics: Multiple Sclerosis (MS), Physicians' Offices, Prescription Drugs
Regions: United States
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
Topics: Multiple Sclerosis (MS)
Regions: Europe
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU
Topics: Marketing, Multiple Sclerosis (MS), Physicians' Offices
Regions: United States
Multiple Sclerosis: KOL Insight
Topics: Multiple Sclerosis (MS), Research & Development


Prev  | 1  | 2  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.